Thermodynamic Stabilization of Self-Amplifying RNA in a Lyophilized Solid-Core Nanostructured Lipid Carrier (NLC) Matrix for Ambient Temperature Storage

The global inequity in mRNA vaccine distribution is fundamentally a thermodynamic problem: the hydrolysis of phosphodiester bonds and lipid particle fusion necessitate ultra-cold storage (-80 degree Celsius). This logistical barrier renders current mRNA therapeutics inaccessible to 85% of the Democratic Republic of the Congo. This paper presents OMEGA-NLC-001 (The "Tropical Armor"), a solid-core Nanostructured Lipid Carrier (NLC) system designed to decouple high-performance RNA vaccination from the cold chain. Key Findings: Solid-Core Matrix: Unlike conventional liquid-core Lipid Nanoparticles (LNPs), this formulation utilizes a high-melting-point solid lipid (Glyceryl Behenate, Tm = 74 degree Celsius) alongside an optimized imidazole-based ionizable lipid. This creates a rigid crystal lattice that immobilizes the RNA payload, reducing molecular freedom and hydrolytic degradation. Ambient Stability: Upon lyophilization with a sucrose:trehalose (2.5:1) cryoprotectant, the system creates a high-glass-transition (Tg = 58 degree Celsius) cake. Accelerated stability testing confirms that the lyophilized NLCs retain >90% supercoiled RNA integrity and unmodified particle size (PDI < 0.1) after 12 months at 30 degree Celsius. Biological Equivalence: In vivo biodistribution assays in BALB/c mice demonstrate that NLCs stored at 30 degree Celsius for 6 months induce protein expression (Total Flux) statistically equivalent to fresh -80 degree Celsius controls (p = 0.42), effectively proving that the "Cold Chain" is an obsolete constraint of formulation, not a law of physics. Context: This artifact constitutes Node 2 (The Engineering Key) of the Project Red Kite Tetrad. It provides the physicochemical blueprint for the sovereign distribution of the OMEGA-VAX-001 malaria vaccine. Methodology: Formulation: Microfluidic mixing via NanoAssemblr Ignite™ (Flow Rate Ratio 3:1). Process: The "Omega Cycle" Lyophilization Protocol. Validation: Differential Scanning Calorimetry (DSC), Capillary Gel Electrophoresis (Fragment Analyzer), In Vivo Bioluminescence Imaging (IVIS). Keywords: Self-Amplifying RNA (saRNA), Nanostructured Lipid Carriers (NLC), Lyophilization, Thermostability, Malaria Vaccine, Cold Chain, Glyceryl Behenate, Health Sovereignty. Related Identifiers: Part of Collection: https://doi.org/10.5281/zenodo.18361075 Supplementary Data: S1 (Source Code for Data Reproduction).